New Breast Cancer Radiotherapy Technology Confers Higher Complications and Costs Before Effectiveness Proven: A Medicare Data Analysis

A new breast cancer treatment, brachytherapy-based accelerated partial breast radiotherapy (RT), was adopted before long-term effectiveness evidence, potentially increasing morbidity and costs compared with whole breast RT. The aim of this study was to estimate complication rates and RT-specific and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Heather T., Walter, Dawn, Tousimis, Eleni, Hayes, Mary Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846914/
https://www.ncbi.nlm.nih.gov/pubmed/29502466
http://dx.doi.org/10.1177/0046958018759115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846914/
https://www.ncbi.nlm.nih.gov/pubmed/29502466
http://dx.doi.org/10.1177/0046958018759115

Ejemplares similares